This edition of the Genetic Technology TOE depicts the current landscape and new life sciences trends across biotechnologies. Innovations profiled are antibody drug conjugates, autosampling platforms, advances in UV light to fight influenza virus, and novel liquid biopsy tests. Clinical trials analysis for Phase 3 studies in Hodgkin’s disease is also depicted.
The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Table of Contents
Recent Advances Across the Global Biotech Landscape
- Novel Antibody Drug Conjugate Platform for Cancer Management
- Autosampling Platform for Protein Stability and Aggregation Testing
- Leveraging UV Light for Killing Influenza Virus
- Novel Liquid Biopsy Test for 26 Cancers
Clinical Trial Analysis and Industry Interactions
- Clinical Trial Analysis for Phase 3 Studies in Hodgkin’s Disease
- Key Contacts
